Serenity

CARNIVAL LUMINOSA OPENS FOR SALE AS THE NEWEST FUN SHIP PREPARES TO JOIN THE CARNIVAL CRUISE LINE FLEET

Retrieved on: 
Wednesday, August 24, 2022
Serenity, Cloud, NYSE, Spirit, Carnival, Carnivàle, Carnival Corporation & plc, Carnival Celebration, Great Barrier Reef, Multimedia, Costa Luminosa, Revolution, Chef's Table, CCL, Steakhouse, Strategic Homeport, Carnival Cruise Line, Love, Travel, Cruise line, Shipbuilding, Conflict Group, RMS Transvaal Castle, BC, LNG

MIAMI, Aug. 24, 2022 /PRNewswire/ -- Carnival Cruise Line announced today that reservations are open for the inaugural season of its newest ship Carnival Luminosa which will debut from Brisbane, Australia Nov. 6, 2022 before repositioning for seasonal service from Seattle to Alaska next May.

Key Points: 
  • "We couldn't be prouder to welcome Carnival Luminosa to our fleet and to start our highly anticipated sailings from Brisbane followed by unique bucket-list itineraries in Alaska ," said Christine Duffy, president of Carnival Cruise Line.
  • Carnival Luminosa is a sister ship to the four other Spirit-class ships that are already popular among Carnival guests.
  • For additional information on Carnival Cruise Line and to book a cruise vacation on Carnival Luminosa now, call 1-800-CARNIVAL, visit www.carnival.com , or contact your favorite travel advisor or online travel site.
  • Carnival Cruise Line, part of Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), is proud to be known as America's Cruise Line.

KaraMD Launches Total Serenity, a Natural Remedy for Mood Enhancement and Stress Relief

Retrieved on: 
Thursday, August 18, 2022
Serenity, GMO, Life, Research, Dietary supplement

CLEVELAND, Aug. 18, 2022 /PRNewswire/ -- KaraMD , a unique line of natural remedies that target digestive and heart health, increasing natural energy and more, announced the launch of Total Serenity , a natural supplement formulated to support stress release and mood enhancement.

Key Points: 
  • CLEVELAND, Aug. 18, 2022 /PRNewswire/ -- KaraMD , a unique line of natural remedies that target digestive and heart health, increasing natural energy and more, announced the launch of Total Serenity , a natural supplement formulated to support stress release and mood enhancement.
  • Total Serenity is a proprietary blend of ashwagandha, Panax ginseng, lion mane's mushroom, lemon balm, L-Theanine, and other natural herbs that are strategically combined to help reduce stress, decrease racing thoughts, and improve overall mood and cognitive health.
  • Mahmud Kara, M.D., founder of KaraMD, developed Total Serenity as a gluten-free, vegan-friendly and non-GMO supplement that complements every type of lifestyle.
  • Formulated with a blend of natural herbs, the Total Serenity supplement is the ultimate veggie capsule for everyday use.

Health Canada Grants MDMA Production and Distribution Amendment to Optimi Health

Retrieved on: 
Tuesday, August 16, 2022
Serenity, Psilocybin, FDA, API, Industry, GLOBE, Clinical trial, Policy, MDMA, Compliance, Patient, Review, Standard operating procedure, Company, Intercept, Health Canada, FRA, EU, Science, CSE, SOP, Social policy of the Joe Biden administration, Online gambling, Pharmaceutical industry

Under the leadership of Chief Science Officer Justin Kirkland, Optimi will now act as wholesale supplier of MDMA and other synthetic psychedelic compounds to approved researchers and drug developers.

Key Points: 
  • Under the leadership of Chief Science Officer Justin Kirkland, Optimi will now act as wholesale supplier of MDMA and other synthetic psychedelic compounds to approved researchers and drug developers.
  • The Company is scheduled to begin production and analytical testing of MDMA this October in its recently completed EU-GMP pharmaceutical manufacturing facility.
  • Optimi CEO, Bill Ciprick, says the Companys in-house capacity to produce a wide range of scalable formulations puts Optimi at the forefront of the commercial manufacturing and supply of psychedelics.
  • In addition to MDMA, the Company now has Health Canada approval to manufacture and distribute additional substances including:

Serenity Launches Healthcare Case Management Service for Expats in Portugal

Retrieved on: 
Friday, August 12, 2022
Medical case management, Case management, CEO, Prescription, Hospital, Timeline of the COVID-19 pandemic in New Zealand (2021), Language, Patient, Mark (given name), Comprehension, Time, Case management (US healthcare system), Health insurance, Medicine, Serenity

Lisbon, Portugal--(Newsfile Corp. - August 12, 2022) - Serenity Care has launched the Case Management service for expats to make the relocation process a seamless one, with regard to all their healthcare needs.

Key Points: 
  • Lisbon, Portugal--(Newsfile Corp. - August 12, 2022) - Serenity Care has launched the Case Management service for expats to make the relocation process a seamless one, with regard to all their healthcare needs.
  • The medical concierge service handles all aspects of healthcare so that they can focus on other aspects of the resettlement process.
  • Serenity Care's Medical Case Management system expedites the process of receiving appropriate healthcare in Portugal.
  • Commenting on the concierge service, Michael Averbukh, CEO and Managing Partner of Serenity said, "Our Medical Case Management Service is ideal for expats seeking reliable, convenient, and personalized options for their healthcare requirements in Portugal.

Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients

Retrieved on: 
Wednesday, August 10, 2022
Serenity, Psilocybin, Death, Interview, Special access program, GLOBE, Phrase, Form, Clinical trial, Cancer, Sale, Biomass, SAP, Panaeolus, Drug prohibition law, Patient, Family, Health Canada, FRA, Controlled Substances Act, Blister, EU, Research, Anxiety, News, CSE, Time, Medicine, Health, FOR, Pharmaceutical industry, Mobile phone, Public relations, Risk management, Cultivation

VANCOUVER, British Columbia, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Canadian-based company licensed by Health Canada to produce natural, scalable, and accessible psychedelic and functional mushrooms, as well as synthetic formulations for transformational human experiences, is celebrating the launch of Blue Serenity, Canada’s first natural therapeutic psilocybin product, in collaboration with psilocybin patient advocate Thomas Hartle.

Key Points: 
  • Once approved by health authorities under Canadas Special Access Program (SAP) or an authorized clinical trial, patients, doctors, and researchers will receive Blue Serenity in blister packs of eight (8) psilocybin capsules.
  • Blue Serenity is packaged according to current regulations and guidelines governing the manufacture and commercial distribution of medical/pharmaceutical products (EU-GMP).
  • We are tremendously excited to be partnering with Thomas to become the first Canadian company to launch a natural psilocybin product specifically to help patients seeking relief through the Special Access Program, he added.
  • Further, Ciprick confirmed that proceeds from the sale of Blue Serenity will directly benefit psilocybin patients through Hartles new charity, a venture that will provide access to psilocybin therapy for underserved adults.

Serenity Launches Medical Concierge Services to Facilitate a Smooth Transition to Portuguese Healthcare System for Expats

Retrieved on: 
Tuesday, August 9, 2022
CEO, Global Retirement Index, Population, Prescription, Language, Mark (given name), Education, Conditional sentence, Diabetes, Time, SNS, Health care, Health insurance, Health, Serenity

Lisbon, Portugal--(Newsfile Corp. - August 9, 2022) - Serenity has launched medical concierge services to facilitate a smooth transition to accessing health care services for expats in Portugal.

Key Points: 
  • Lisbon, Portugal--(Newsfile Corp. - August 9, 2022) - Serenity has launched medical concierge services to facilitate a smooth transition to accessing health care services for expats in Portugal.
  • Portugal was ranked as the 4th best place to retire in 2022 according to the Global Retirement Index.
  • The healthcare system in Portugal comprises the public healthcare service called the Servio Nacional de Sade or SNS and a private healthcare system that can be accessed by those having private health insurance.
  • Navigating this process, especially in the event of an illness can be confusing, and this is where the services of a medical concierge company, like Serenity, can help make a difference.

Acerus Reports Second Quarter 2022 Financial Results

Retrieved on: 
Tuesday, August 9, 2022
FDA, Endocrinology, Pharmacy, Budget, International Financial Reporting Standards, Income tax, GLOBE, ASP, Growth, TSX, Prescription, Board, Three Months Gone, Adjustment, Income, First generation, Marketing, Company, International, Twitter, Acquisition, Depreciation, IFRS, Health Canada, Sanofi, Research, OTCQB, SWK, LinkedIn, Total, Testosterone (medication), Security (finance), Pharmaceutical industry, Video game, Oil, Bookkeeping, Urology, Pristimantis acerus, EBITDA, Serenity

TORONTO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (Acerus or the Company) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and six-month period ended June 30, 2022.

Key Points: 
  • TORONTO, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (Acerus or the Company) (TSX: ASP; OTCQB: ASPCF) today reported its financial results for the three and six-month period ended June 30, 2022.
  • Gross profit for the second quarter of 2022 was $0.3 million compared to $0.5 million in the prior-year period.
  • Second quarter selling, general and administrative expense (SG&A) declined by $1.4 million, to $4.9 million, from $6.3 million in the second quarter of 2021.
  • Shareholders are reminded that the conference call to discuss the Companys results for the second quarter will be held on August 9, 2022 at 10:00 a.m. Eastern Time.

Serenity Shield Launches First Cryptographic Sensitive Data Storage and Succession Solution on Blockchain

Retrieved on: 
Monday, August 8, 2022
Serenity, Death, MVP, Maxima and minima, Privacy, Decentralized application, Technology, Digital rights, Blockchain, Architecture, Founder CEO, Minimum viable product, UI, Ownership, Insurance, Solution, Innovation, MetaMask, Adoption, Cryptocurrency

Employing privacy-by-design, Serenity Shield's patent-pending StrongBox DApp technology allows users to:

Key Points: 
  • Employing privacy-by-design, Serenity Shield's patent-pending StrongBox DApp technology allows users to:
    store, preserve, and restore their data in case of loss of access to their sensitive information.
  • To achieve this, Serenity Shield has chosen Secret Network, a private smart contract blockchain system, to store confidential information, as it offers the security and privacy-by-design features required.
  • The Serenity Shield MVP is a cross-chain solution whose primary base is Solana.
  • Thanks to this disruptive technology development, Serenity Shield is positioned more broadly as a consolidator among all existing blockchain solutions.

Acerus Announces Amendments to Loan Facility and Promissory Note Due to Former Serenity Shareholders

Retrieved on: 
Friday, August 5, 2022
Serenity, Term Asset-Backed Securities Loan Facility, Lead, GLOBE, ASP, TSX, Board, Director, Loan, First generation, Review, Company, Twitter, First, Note, OTCQB, LinkedIn, Time, Bank, Security (finance), Pristimantis acerus

The Loan Facility bears interest at a rate of eight percent (8%) per annum and is repayable in full on December 31, 2024 but can be prepaid in full or in part without penalty.

Key Points: 
  • The Loan Facility bears interest at a rate of eight percent (8%) per annum and is repayable in full on December 31, 2024 but can be prepaid in full or in part without penalty.
  • The proceeds from the Loan Facility will be used for ongoing general working capital.
  • Following the review of such independent members of the Board of Directors, it was unanimously determined that the entering into of the amendment to the Loan Facility was in the best interests of Acerus.
  • In addition, the Company today announced that it has amended the promissory note (the Note) in the amount of US$4.91 million related to the up-front fee owed to former Serenity Pharmaceuticals LLC (Serenity) securityholders.

Proactive news headlines including Surefire Resources, Creso Pharma, Emyria Ltd and Moho Resources

Retrieved on: 
Thursday, August 4, 2022
Serenity, Lithium, Well, JRL, OTCQB, BRK, CML, OTC, Bluegrass, DFS, AOI, Sammons, RC, Granite Flats, The Long canyon (quarry), Mike Piazza, Gold, GLOBE, RAD, Proactivity, WBP, LIN, Chase, Acquisition, DTM, Program, BNL, News, ASX, CPH, Mining, Security (finance), Oil, Rare-earth element, Callisto

Click here

Key Points: 
  • Click here
    Moho Resources Ltd (ASX:MOH) is making strong progress with nickel sulphide exploration programs at the Silver Swan North Project in Western Australia.
  • Click here
    Jindalee Resources Ltd (ASX:JRL) has welcomed highly experienced lithium industry executive Darren Wates to the board as an independent non-executive director.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]